Sign Out
ANORO ELLIPTA is for oral inhalation only.
ANORO ELLIPTA should be administered once daily at the same time each day.
Adults: The recommended and maximum dose is one inhalation of ANORO ELLIPTA 62.5/25 micrograms once daily.
Children: Use in patients less than 18 years of age is not relevant given the indication for this product.
Elderly: No dosage adjustment is required in patients over 65 years (see Pharmacology: Pharmacokinetics: Special Patient Populations under Actions).
Renal impairment: No dosage adjustment is required in patients with renal impairment (see Pharmacology: Pharmacokinetics: Special Patient Populations under Actions).
Hepatic impairment: No dosage adjustment is required in patients with mild or moderate hepatic impairment. ANORO ELLIPTA has not been studied in patients with severe hepatic impairment (see Pharmacology: Pharmacokinetics: Special Patient Populations under Actions).
